[A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Investigation of sulodexide effects on renal function, hemostasis and lipid metabolism in patients with diabetes mellitus. 20 diabetics (diabetes mellitus type I and II) received sulodexide (Vessel due F) for 3 weeks. This mixture of low molecular heparin and dermatan sylphate was injected i.m. once a day for 5 days a week with a 2-day interval. Micro- and macro-albuminuria diminished after treatment but further returned to baseline levels. The rate of glomerular filtration, blood levels of glucose and cholesterol, hemostatic parameters remained unchanged. Blood triglycerides fell. Sulodexide may be useful in pathogenetic treatment of diabetic nephropathy.